Profile
Xiao Lin Wang worked as the VP-Biometrics & Development Operations at Geron Corp.
from 2010 to 2015.
From 2015 to 2018, she held the position of Vice President-Biometrics at Acerta Pharma LLC.
Currently, she is the Executive Vice President-Clinical Development at Revolution Medicines, Inc. starting from 2018.
Dr. Wang holds a doctorate degree from Harvard University, a graduate degree from the University of Washington, and an undergraduate degree from Peking University.
Former positions of Xiao Lin Wang
| Companies | Position | End |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 2023-03-31 |
| Acerta Pharma LLC | Corporate Officer/Principal | 2018-02-28 |
| GERON CORPORATION | Corporate Officer/Principal | 2015-04-30 |
Training of Xiao Lin Wang
| Harvard University | Doctorate Degree |
| University of Washington | Graduate Degree |
| Peking University | Undergraduate Degree |
Experiences
Positions held
Connections
42
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Acerta Pharma LLC |
- Stock Market
- Insiders
- Xiao Lin Wang
